Both in Pharmaceuticals
Precigen vs Xeris Biopharma Holdings
Over the past year PGEN returned +26.2% and XERS returned +4.5%; their daily moves had a correlation of 0.18.
PGEN +26.2% XERS +4.5%Growth of $1, one year, split-adjusted
| Metric | PGEN | XERS |
|---|---|---|
| Price | $5.25 | $10.35 |
| Market cap | $1.88B | $1.89B |
| Today | +2.14% | +1.77% |
| 1 month | −32.2% | +2.2% |
| 6 months | +21.2% | +66.1% |
| Year to date | +25.6% | +31.8% |
| 1 year | +26.8% | +6.7% |
| Revenue growth (YoY) | +6322.7% | +28.7% |
| Gross margin | 94.9% | 86.4% |
| Net margin | 36.5% | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | 21.9× | 5.6× |
| Net cash | -$55.7M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 86.6% | 52.4% |
| Short % of float | 26.1% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).